Literature DB >> 33111131

Temporal and spatial concomitance of exanthema and dysesthesia in a patient with SARS-cov-2 infection.

Eric Denes1.   

Abstract

Entities:  

Keywords:  COVID-19; Dysesthesia; Exanthema; SARS-Cov-2

Year:  2020        PMID: 33111131      PMCID: PMC7582041          DOI: 10.1016/j.bbih.2020.100165

Source DB:  PubMed          Journal:  Brain Behav Immun Health        ISSN: 2666-3546


× No keyword cloud information.
To the editor, We’ve read with interest the article by Liguori (Liguori et al., 2020) and the answer by Krajewski (Krajewski et al., 2020) and particularly the description of dysesthesia. We would like to add to these descriptions the case of another patient with dysesthesia while adding new elements in understanding the pathophysiology of these latter. Indeed, we observed a patient who simultaneously presented dysesthesia and a viral exanthema in the same skin areas. The patient is a 50-years-old male without any past medical history who presented a fever of 38.2 ​°C and dry cough associated with myalgia. The SARS-Cov-2 infection was documented thanks to RT-PCR. On day 2 after the onset of disease, dysesthesia appeared acutely on his back, the back of both arms and the chest. Symptoms followed metameres (Proximal part of C7–C8 and from T2 to T9), were symmetrically distributed and had the same intensity in all areas. Sensations were increased by pressure and touch such as clothes, backpack, or movements of the car seat … It was particularly true during the night while moving in bed. Symptoms were calmed down by warm such as shower or sweating but only for a short period. Interestingly, a slight exanthema was present in the same areas and only where neurological symptoms were present (Fig. 1 and Fig. 2). No treatment was given. Neurological manifestations and exanthema last for five days and progressively disappeared. Curiously, anosmia and dysgeusia appeared as the other neurological manifestations disappeared.
Fig. 1

Exanthema present on the back.

Fig. 2

Exanthema on the chest.

Exanthema present on the back. Exanthema on the chest. Apart one of the two patients reported by Krajewski (Krajewski et al., 2020) we found, in the literature, another patient who presented skin exanthema and paraesthesia (Tatu et al., 2020). However, no details about a potential link between skin eruption and neurological manifestations are given. Contrary to our case, it seems, that for the second patient described by Krajewski (Krajewski et al., 2020) neurological and skin manifestations were spatially dissociated. Exact pathophysiology of exanthema during viral infection is not clearly known but antigens-antibodies complexes are widely reported as a potential explanation (Gupta et al., 2020; Mims, 1966). Dysesthesia is the consequence of peripheral nerve damage (Asbury and Fields, 1984) and could be in part in relation to small fibers inflammation (Levine, 2018). In our case, the metameric distribution advocates for a direct effect of the virus on neurological fibres in relation with its neurotropic characteristics (Liguori et al., 2020; Zhou et al., 2020). The concomitance (temporal and spatial) of skin and neurological manifestations let us think of local inflammation due to immune reaction against virus which could have led to exanthema and part of small fibers inflammation. Other case of such manifestations could help understanding this complex disease with neurological and skin tropism, especially if skin biopsy could be performed.
  5 in total

Review 1.  Pathogenesis of rashes in virus diseases.

Authors:  C A Mims
Journal:  Bacteriol Rev       Date:  1966-12

2.  Pain due to peripheral nerve damage: an hypothesis.

Authors:  A K Asbury; H L Fields
Journal:  Neurology       Date:  1984-12       Impact factor: 9.910

Review 3.  Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.

Authors:  Zhiqiang Zhou; Huicong Kang; Shiyong Li; Xu Zhao
Journal:  J Neurol       Date:  2020-05-26       Impact factor: 4.849

4.  Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.

Authors:  Claudio Liguori; Mariangela Pierantozzi; Matteo Spanetta; Loredana Sarmati; Novella Cesta; Marco Iannetta; Josuel Ora; Grazia Genga Mina; Ermanno Puxeddu; Ottavia Balbi; Gabriella Pezzuto; Andrea Magrini; Paola Rogliani; Massimo Andreoni; Nicola Biagio Mercuri
Journal:  Brain Behav Immun       Date:  2020-05-19       Impact factor: 7.217

5.  Cutaneous hyperesthesia: A novel manifestation of COVID-19.

Authors:  Piotr K Krajewski; Jacek C Szepietowski; Joanna Maj
Journal:  Brain Behav Immun       Date:  2020-05-25       Impact factor: 7.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.